Flatt Jumps to Synthetic Genomics

San Diego’s Synthetic Genomics, which said last year it’s getting at least $300 million from ExxonMobil to develop algae-based biofuels, has named James Flatt as its new chief technology officer, effective May 19. Flatt previously served as the senior vice president of research at Mascoma Biosciences, a cellulosic ethanol developer that moved last fall from Boston to Lebanon, NH.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @bvbigelow

Trending on Xconomy